查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600445

抗苗勒管激素測試市場：按產品、最終用戶、分銷、應用 - 全球預測 2025-2030

Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年抗苗勒氏管激素檢測市值為27426萬美元，預計2024年將達到30541萬美元，複合年成長率為11.46%，到2030年將達到58648萬美元。

抗苗勒氏管激素 (AMH) 測試可測量血液中的 AMH 水平，並為卵巢儲備、生育能力和生育治療計劃提供重要見解。 AMH 檢測的需求源自於不孕症評估、閉經預測、卵巢症候群 (PCOS) 診斷以及癌症治療期間卵巢功能評估的應用。最終用途範圍主要包括生育診所、實驗室、醫院和診斷中心。不孕症盛行率的上升、生殖醫學意識的提高以及檢測技術的進步正在推動市場的成長。新的機會出現在個人化醫療以及將 AMH 檢測納入更廣泛的生育治療計劃中。 AMH檢測的應用也可能擴大到男性內分泌學和兒科內分泌學。主要建議包括投資於技術進步，例如就地檢驗套件，以提高可及性和準確性，並探索與生育診所建立合作夥伴關係以尋求全面解決方案。

主要市場統計
基準年[2023] 27426萬美元
預測年份 [2024] 30541萬美元
預測年份 [2030] 5.8648億美元
複合年成長率（%） 11.46%

影響市場開拓的限制包括測試成本高、新興市場認知度低以及測試解釋的變異性。此外，圍繞不孕症治療的倫理問題和監管挑戰也可能阻礙市場進步。為了應對這些問題，有針對性的宣傳活動和津貼測試方案可能會有所幫助。創新可以集中於開發具有成本效益的測試，以快速提供結果，並利用人工智慧在生殖醫學中進行更好的預測分析。此外，對 AMH 廣泛適用性（包括其在各種疾病狀態中的作用）的生物技術研究可能會開闢新的途徑。市場的性質表明競爭格局存在地區差異，北美和歐洲占主導地位，但亞太地區擁有巨大的開拓潛力。市場相關人員正在探索策略夥伴關係，以提高市場滲透率並滿足這些新興地區的需求，同時平衡不孕症診斷的方面和社會文化方面，並鼓勵投資於教育措施。

市場動態：揭示快速發展的抗苗勒氏管激素測試市場的關鍵市場洞察

供需的動態交互作用正在改變抗苗勒氏管激素檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球卵巢症候群盛行率不斷上升
    • 體外受精及卵子冷凍手術數量增加
  • 市場限制因素
    • AMH 測試的報銷限額
  • 市場機會
    • 抗苗勒氏管激素檢測技術的進展
    • 政府提高生殖和不孕不育健康意識的舉措
  • 市場問題
    • 與抗苗勒氏管激素檢測套組相關的矛盾和錯誤結果

波特五力：駕馭抗苗勒氏管激素測試市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解抗苗勒氏管激素檢測市場的外部影響

外部宏觀環境因素在塑造抗繆勒氏管激素測試市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解抗苗勒氏管激素檢測市場的競爭格局

抗苗勒管激素測試市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：抗苗勒氏管激素測試市場供應商的績效評估

FPNV 定位矩陣是評估抗苗勒管激素測試市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

該報告提供了涵蓋關鍵焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的廣泛資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球多卵巢症候群盛行率上升
      • 體外受精和卵子冷凍手術的增加
    • 抑制因素
      • AMH 測試的退款是有限的。
    • 機會
      • 抗苗勒氏管激素檢測技術的進展
      • 政府採取措施提高人們對生殖和不孕症健康的認知
    • 任務
      • 與抗穆氏管荷爾蒙套件相關的不一致和不正確的結果
  • 市場區隔分析
    • 產品：消費者對POC測試以獲得專家監督的偏好正在增加
    • 最終用戶：AMH檢測套組在商業實驗室中越來越受歡迎，可提供準確、快速的結果
    • 分銷：提高 AMH檢測套組在線上通路的可用性
    • 應用：AMH檢測套組在人體應用的重要用途
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章抗苗勒氏管激素檢測市場：分產品

  • 介紹
  • POC測試
  • 自檢套件

第7章 抗苗勒氏管激素測試市場：依最終用戶分類

  • 介紹
  • 商業實驗室
  • 研究與開發

第8章抗苗勒氏管激素檢測市場：依分佈

  • 介紹
  • 線下通路
  • 線上通路

第9章抗苗勒氏管激素檢測市場：依應用分類

  • 介紹
  • 人類
  • 非人類靈長類動物

第10章美洲抗苗勒氏管激素檢測市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區抗苗勒氏管激素檢測市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲抗苗勒氏管激素檢測市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 西門子 Healthineers 採用新的卵巢儲備評估方法
    • ARUP 實驗室以 MenoCheck 徹底改變更年期管理
    • 推出 Elecsys抗穆氏管荷爾蒙加免疫檢測，以提高可及性和早期檢測
    • 使用 Fertilly 的創新家用不孕症測試進行抗穆氏管荷爾蒙分析，了解您的生殖健康狀況
    • SD Biosensor 和 SJL Partners 對 Meridian Bioscience 的策略性收購增強了成長和全球影響力
    • Randox 品質控制推出先進的 Acusera AMH 控制來增強生殖測試

公司名單

  • Abbexa Limited
  • Abcam PLC
  • Ansh Labs LLC
  • Athenese-Dx
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux SA
  • BioVendor-Laboratorni Medicina AS
  • Chengdu VACURE BIoTechnology Co., Ltd.
  • CTK BIoTech, Inc.
  • Cusabio Technology LLC
  • Eagle Biosciences, Inc.
  • Elabscience Bionovation Inc.
  • Epitope Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Europe NV by HU Group Holdings, Inc.
  • Goldsite Diagnostics Inc.
  • Healthy Human Labs Limited（Vitall）
  • Kamiya Biomedical Company
  • LifeSpan BioSciences, Inc.
  • London Gynaecology Limited
  • Meridian Bioscience, Inc.
  • Monobind Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • Vitrosens BIoTechnology Co., Ltd.
Product Code: MRR-BC3400CDF7AF

The Anti-Mullerian Hormone Test Market was valued at USD 274.26 million in 2023, expected to reach USD 305.41 million in 2024, and is projected to grow at a CAGR of 11.46%, to USD 586.48 million by 2030.

The Anti-Mullerian Hormone (AMH) Test measures the level of AMH in blood, offering vital insights into ovarian reserve, fertility potential, and planning fertility treatments. The necessity of AMH testing arises from its applications in fertility assessments, predicting menopause onset, diagnosing polycystic ovarian syndrome (PCOS), and evaluating ovarian function during cancer treatments. The end-use scope primarily includes fertility clinics, research laboratories, hospitals, and diagnostic centers. The rising prevalence of infertility, increasing awareness of reproductive health, and advancements in testing technologies drive the market growth. Emerging opportunities are seen in personalized medicine and the integration of AMH testing within broader fertility treatment plans. There is potential in expanding AMH test applications in male and pediatric endocrinology as well. Key recommendations include investing in technological advancements such as point-of-care testing kits to improve accessibility and accuracy, and exploring collaborations with fertility clinics for integrated solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 274.26 million
Estimated Year [2024] USD 305.41 million
Forecast Year [2030] USD 586.48 million
CAGR (%) 11.46%

Limitations affecting market growth include the high cost of testing, limited awareness in developing regions, and variability in test interpretation. Moreover, ethical concerns surrounding fertility treatments and regulatory challenges might hinder market progress. To counteract these, targeted awareness campaigns and subsidized testing options may prove beneficial. Innovations could focus on developing cost-effective testing methods that provide rapid results, or leveraging AI for better predictive analytics in reproductive health. Furthermore, biotechnological research into AMH's broader applicability, such as its role in various medical conditions, could open new avenues. The market nature suggests a competitive landscape with regional disparities in adoption rates, dominated by North America and Europe but with significant untapped potential in Asia-Pacific. Market players are encouraged to explore strategic partnerships and invest in educational initiatives to enhance market penetration and address demand in these emerging regions, balancing both the technical and socio-cultural facets of fertility diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Mullerian Hormone Test Market

The Anti-Mullerian Hormone Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of polycystic ovary syndrome worldwide
    • Growing number of IVF and egg-freezing procedures
  • Market Restraints
    • Limited reimbursements available for AMH tests
  • Market Opportunities
    • Advancements in anti-Mullerian hormone test technology
    • Government initiatives for creating awareness associated with reproductive and infertility treatment health
  • Market Challenges
    • Inconsistencies and false results associated with anti-Mullerian hormone kits

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Mullerian Hormone Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Mullerian Hormone Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Mullerian Hormone Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Mullerian Hormone Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Mullerian Hormone Test Market

A detailed market share analysis in the Anti-Mullerian Hormone Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Mullerian Hormone Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Mullerian Hormone Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Anti-Mullerian Hormone Test Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam PLC, Ansh Labs LLC, Athenese-Dx, Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux S.A., BioVendor - Laboratorni Medicina A.S., Chengdu VACURE Biotechnology Co., Ltd., CTK Biotech, Inc., Cusabio Technology LLC, Eagle Biosciences, Inc., Elabscience Bionovation Inc., Epitope Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Fujirebio Europe N.V. by H.U. Group Holdings, Inc., Goldsite Diagnostics Inc., Healthy Human Labs Limited (Vitall), Kamiya Biomedical Company, LifeSpan BioSciences, Inc., London Gynaecology Limited, Meridian Bioscience, Inc., Monobind Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tosoh Corporation, and Vitrosens Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Anti-Mullerian Hormone Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across POC Testing and Self-check Kits.
  • Based on End-User, market is studied across Commercial Labs and Research & development.
  • Based on Distribution, market is studied across Offline Channels and Online Channels.
  • Based on Use, market is studied across Human and Non-Human Primate.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of polycystic ovary syndrome worldwide
      • 5.1.1.2. Growing number of IVF and egg-freezing procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Limited reimbursements available for AMH tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in anti-Mullerian hormone test technology
      • 5.1.3.2. Government initiatives for creating awareness associated with reproductive and infertility treatment health
    • 5.1.4. Challenges
      • 5.1.4.1. Inconsistencies and false results associated with anti-Mullerian hormone kits
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing consumer preference for POC testing to obtain professional oversight
    • 5.2.2. End-User: Rising penetration of AMH test kits in commercial labs for accurate and rapid results
    • 5.2.3. Distribution: Emerging availability of AMH testing kits on online channels
    • 5.2.4. Use: Significant usage of AMH testing kits for human applications
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anti-Mullerian Hormone Test Market, by Product

  • 6.1. Introduction
  • 6.2. POC Testing
  • 6.3. Self-check Kits

7. Anti-Mullerian Hormone Test Market, by End-User

  • 7.1. Introduction
  • 7.2. Commercial Labs
  • 7.3. Research & development

8. Anti-Mullerian Hormone Test Market, by Distribution

  • 8.1. Introduction
  • 8.2. Offline Channels
  • 8.3. Online Channels

9. Anti-Mullerian Hormone Test Market, by Use

  • 9.1. Introduction
  • 9.2. Human
  • 9.3. Non-Human Primate

10. Americas Anti-Mullerian Hormone Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anti-Mullerian Hormone Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anti-Mullerian Hormone Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Introduction of Novel Assay by Siemens Healthineers' for Assessing Ovarian Reserve
    • 13.3.2. The Introduction of MenoCheck by ARUP Laboratories to Revolutionizing Menopausal Management
    • 13.3.3. The Advent of the Elecsys Anti-Mullerian Hormone Plus immunoassay for Enhanced Accessibility and Early Detection
    • 13.3.4. Innovative At-Home Fertility Test by Fertilly for Understanding Reproductive Health through Anti-Mullerian Hormone Analysis
    • 13.3.5. Strategic Acquisition of Meridian Bioscience by SD Biosensor and SJL Partners for Enhanced Growth and Global Impact
    • 13.3.6. Randox Quality Control Introduces Advanced Acusera AMH Control for Enhanced Reproductive Testing

Companies Mentioned

  • 1. Abbexa Limited
  • 2. Abcam PLC
  • 3. Ansh Labs LLC
  • 4. Athenese-Dx
  • 5. Beckman Coulter, Inc. by Danaher Corporation
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. bioMerieux S.A.
  • 9. BioVendor - Laboratorni Medicina A.S.
  • 10. Chengdu VACURE Biotechnology Co., Ltd.
  • 11. CTK Biotech, Inc.
  • 12. Cusabio Technology LLC
  • 13. Eagle Biosciences, Inc.
  • 14. Elabscience Bionovation Inc.
  • 15. Epitope Diagnostics, Inc.
  • 16. F. Hoffmann-La Roche Ltd.
  • 17. Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
  • 18. Goldsite Diagnostics Inc.
  • 19. Healthy Human Labs Limited (Vitall)
  • 20. Kamiya Biomedical Company
  • 21. LifeSpan BioSciences, Inc.
  • 22. London Gynaecology Limited
  • 23. Meridian Bioscience, Inc.
  • 24. Monobind Inc.
  • 25. Siemens Healthineers AG
  • 26. Thermo Fisher Scientific Inc.
  • 27. Tosoh Corporation
  • 28. Vitrosens Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTI-MULLERIAN HORMONE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. ANTI-MULLERIAN HORMONE TEST MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN PRIMATE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 20. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 21. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 22. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 23. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 24. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 25. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 26. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 27. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 28. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 29. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 30. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 31. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 32. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 33. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 34. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 35. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 36. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 37. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 38. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 39. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 40. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 41. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 42. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 43. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 44. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 45. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 46. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 47. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 48. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 49. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 50. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 51. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 52. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 53. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 54. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 55. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 56. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 57. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 58. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 59. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 60. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 61. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 62. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 63. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 64. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 65. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 66. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 67. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 68. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 69. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 70. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 71. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 72. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 73. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 74. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 75. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 77. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 78. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 79. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 80. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 81. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 82. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 83. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 84. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 85. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 86. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 87. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 88. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 89. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 90. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 91. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 92. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 93. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 94. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 95. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 96. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 97. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 103. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 104. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 105. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 106. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 107. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 108. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 109. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 110. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 111. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 112. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 113. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 114. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 115. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 116. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 117. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 118. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 119. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 120. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 121. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 122. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 123. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 124. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 125. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 126. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 127. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 128. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 129. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 130. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 131. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 132. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 133. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 134. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 135. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 136. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 138. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 139. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 140. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 141. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 142. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 143. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 144. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 145. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 146. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 147. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 148. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 149. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 150. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 151. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 152. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 153. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 154. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 155. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 156. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 157. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 158. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 159. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 160. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 161. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 162. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 163. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 164. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 165. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 166. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 167. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 168. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 169. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 170. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 171. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 172. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 173. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 174. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 175. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 176. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 177. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 178. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 179. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 180. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 181. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 182. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 183. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 184. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 185. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
  • TABLE 186. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
  • TABLE 187. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023